$NBIS

Boynton John Wilson IV sold $12K of NBIS

Boynton John Wilson IV sold 50 shares of Nebius Group N.V. (NBIS) at $235.01 on 2026-09-29 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Boynton John Wilson IV
Published Oct 1, 2026, 1:24 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 1, 2026, 1:29 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$NBIS
Neutral
high confidence
Mentioned
$NBIS
Relevance
2/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$NBISNeutralLow
01

Why it matters

The disclosed sale is small relative to total holdings and unlikely to move the stock significantly.

02

Market read

Routine insider sale with limited impact on price; low trading relevance.

03

What to watch

No material corporate event accompanies the sale; investors may ignore it.

Relevance 2/10Novelty 2/10Timing: filing date 2026‑10‑01

Background

SEC Form 4 filing discloses insider transactions, providing transparency on insider holdings.

Company-level read

Ticker impact

$NBISNeutralHigh confidence
Context

Director Boynton John Wilson IV sold 50 shares for $11,750.50 via a 10b5‑1 plan, reducing his holdings to 410,782 shares.

Expected impact

possible slight downward pressure as the market prices the insider's sale.

Evidence & confidence

The transaction size is modest ($12K) and typical for a 10b5‑1 plan, offering limited new information for traders.

Market effects

None

None

None

Counterpoint

The sale may be routine and not indicative of negative sentiment.

Key entities

  • Nebius Group N.V.

    Issuer of the securities sold.

  • Boynton John Wilson IV

    Director and insider selling shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$NBISMed

Nebius stock breaks below $200 as CoreWeave’s debt scare spreads

Nebius Group (NBIS) fell 10.1% to $186.01 on October 14, 2026, breaking its $200 support level. The decline was driven by fears of excessive debt in the AI sector, sparked by CoreWeave (CRWV) bonds yielding near 15%. Nebius's funding costs may rise due to this market sentiment. The company's stock trades at 38x trailing sales and 7x forward sales, with analysts' price targets ranging from $84 to $410.

$NBISMed

Why is Nebius stock sliding today?

Nebius Group NV (NBIS) stock fell 4.1% to $178.4 in pre-open trading, extending losses due to rising borrowing costs, higher bond yields for peer CoreWeave, and Gartner's warning about AI infrastructure spending risks. Insider selling and a bearish stance from short-seller Michael Burry also contributed. The broader tech sector selloff, driven by higher Treasury yields, added pressure.

$NBISMed

Nebius Group (NBIS) Shares Drop 10% Amid Tech Sell-Off; P/S Rati

Nebius Group (NBIS) shares fell 10.08% to $186.01 on October 14, 2026, amid a broader tech sector sell-off. The company's P/S ratio is 38.39, significantly above its historical median and industry norms. Nebius has a GF Score of 52, with strong momentum but weak valuation and financial strength. Insiders have sold $318.2 million in shares over the past year, while some institutional investors have increased their stakes.